A 2012 update on inflammatory cytokines and adipokines: Revelance for CKD

Size: px
Start display at page:

Download "A 2012 update on inflammatory cytokines and adipokines: Revelance for CKD"

Transcription

1 EURECA-m CME COURSE Cardiovascular Problems and Solutions in Chronic Kidney Disease September 7-8, 2-012, Ankara-Turkey A 2012 update on inflammatory cytokines and adipokines: Revelance for CKD Prof. Andrzej Więcek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia, Katowice, Poland awiecek@spskm.katowice.pl

2 Prevalence of obesity in the USA and in Europe In USA: the age-adjusted prevalence of obesity (BMI 30 kg/m 2 ) was 33.8% overall, 32.2% among men, and 35.5% among women the corresponding prevalence estimates for overweight and obesity combined (BMI 25) were 68.0%, 72.3% and 64.1% Flegal K et al. JAMA. 2010; 303: In Europe: the prevalence of obesity (BMI 30 kg/m 2 ) in men ranged from 4.0% to 28.3% and in women from 6.2% to 36.5% Berghöfer A et al. BMC Public Health. 2008; 8: 200

3 Prevalence of obesity in Poland Obesity (BMI > 30 kg/m 2 ) Zdrojewski T. et al., NATPOL III Study, 2011

4 Obese female mammoth ivory figurine produced at least calender years ago (Aurignacien period) and found in the Hohler Fels cave in southwestern Germany Conard D.J, Nature, 2009, 459,

5 Obesity in the Paleolithic era The Venus of Willendorf is a superbly crafted sculpture of a naked obese woman from the stone age Colman M.D. E. Endocr Pract. 1998, 4: 58-59

6 Body-Mass Index and mortality among 1.46 million white adults x Estimated Hazard Rati for death from any cause according to BMI for all study participants and for healthy subjects who never smoked de Gonzales et al. N. Eng. J. Med. 2010; 363:

7 Adjusted relative risk for end-stage renal disease (ESRD) by body mass index (BMI) Model adjusted for multiphasic health checkup period, age, sex, race, education level, smoking status, history of myocardial infarction, serum cholesterol level, proteinuria, haematuria and serum creatinine evel. Hsu et al. Ann Intern Med. 2006; 144: 21 28

8 Distribution of body mass index (BMI) in dialysis patients (based on USRDS) Zoccali C., Mallamaci F.,J. Internal Med., 2011, 269,

9 White adipose tissue in the lean and obese state Adipocytes are shown with yellow triglyceride droplets and blue cytoplasm. In the lean state the light blue cytoplasm represent a state of normoxia, whereas the dark blue in the obese state represents a hypoxic state. Pre adipocytes are shown in brown, macrophages in green, blood vessels/endothelial cells in red, and the extracellular matrix as black. Lean state Obese state Halberg N et al. Endocrinol Metab Clin North Am. 2008; 37: 753

10 Cardiovascular and reologic effects, sleep apnea Renal effects Activation of the sympathetic nervous system Metabolic effects (dyslipidemia, carbohydrate intolerance) Endocrine effects (hyperinsulinism, insulin resistance, hypercortisolism, increased erythropoietin secretion) Increased coagulation/decreased fibrinolysis ( PAI) Haematologic effects NF B PAI Leptin Adiponectin TNF Angiotensin Resistin Adipocytes Obesity Więcek A. et al., Nephrol. Dial. Transplant. 2002; 17;

11 Więcek A. et al. Nephrol. Dial. Transplant. 2007, 22:

12 The major physiological functions of adipose tissue secretory products in 2012 Adamczak M., Wiecek A., Sem. Nephrol., 2012, in press

13 Relationship between body fat mass and plasma adipocytokine levels Shoji T et al.: Metabolism 2005; 54:

14 Effects of peripheral hormones on hypothalamic regulation of food intake and energy expenditure + CKD Engineer D.R., Garcia J.M., Intern. J. Peptides, 2012, ID

15 Markers of appetite regulation in various cachectic states

16 Leptin a new uraemic toxin? or Leptin marker of nutrition?

17

18 (BMI) Plasma leptin and CRP concentration at baseline and 12 months after initialion of HD therapy

19 Leptin is a marker of nutrition: 1. Postive correlation with fat tissue: a) low BMI = low serum leptin concentation b) caloric suplemenation increases body fat mass and median serum leptin concentration 2. Markedly elevated serum leptin concentration does not suppress appetite in uraemic patients (leptin resistance). Uraemia is characterised by relative resistance to many hormones (PTH, HGH, Insulin) and cytokines: a) Serum leptin increses and serum CRP decreases in those HD patiens who gain weight after 12 months after initiation of HD treatment

20 Circulating adiponectin concentrations ADIPONECTIN Scherer Ph. E., Diabetes, 2006, 55,

21 Relationship between body fat mass and plasma adipocytokine levels Shoji T et al.: Metabolism 2005; 54:

22 Circulating forms of adiponectin Adamczak M., Chudek J., Wiecek A., Sem. Dial., 2009, 22,

23 Adiponectin multimerization three major forms of adiponectin found in circulation Scherer Ph. E., Diabetes, 2006, 55,

24 Adiponectin, adiponectin receptors and intracellular signalling Hui X. et al., Brit. J. Pharmacol., 2012, 165,

25 The pleiotropic role of adiponectin in the cardiovascular system Hui X. et al., Brit. J. Pharmacol., 2012, 165,

26 lipids accumulation in monocyte derived PDGF-BB FGF TNF-α glucose macrophages HB EGF utilization transformation of macrophages into foam cells fatty acid oxidation scavenger receptors Adiponectin insulin signalling superoxide glucose uptake VCAM-1 ICAM-1 E-selectin TIMP anti-atherogenic actions NO Więcek A. et al. Nephrol Diali Transplant 2007, 22: gluconeogenesis insulin-sensitizing actions

27 Adiponectin synthesis and biodegradation in patients with chronic kidney disease Adamczak M., Chudek J., Wiecek A., Sem. Dial., 2009, 22,

28 Adipokines and HOMA-IR in non-obese PD patients HOMA-IR is inversly correlated with plasma adiponectin concentration in PD patients Yoo D.E. et al. Endocrine J., 2012 in press

29 Plasma adiponectin concentration and insulin, HDL, CRP levels, and LVMI in hemodialysis patients Abdallah E. et al. Kidney Blood Pres. Res., 2012, 35,

30 Survival curves for analysis of time to cardiovacular events in hemodialysis patients Group 1. Adiponectin <15.1 ug/ml Group 2. Adiponectin > 15.1 ug/ml p< Abdallah E. et al. Kidney Blood Pres. Res., 2012, 35,

31 Kaplan-Meier survival curves for cardiovascular events (fatal and nonfatal) in patients witch chronic renal failure ADPN ADPN ADPN Zoccali C. et al., J. Am. Soc. Nephrol., 2002, 13,

32 Interventions known to increase adiponectin levels Barseghian A. et al. J Am Coll Cardiol. 2011,57,

33 Perivascular white adipose tissue (pwat) as a paracrine regulator of inflammation and atherosclerosis Juge-Aubry C.E. et al., Best Practice Res., Clin. Endocrinol. Metab., 2005, 19,

34 The adipose renin-angiotensin system Dorresteijn J.A.N. et al., Obesity Rev. 2012, 13, 17-26

35 Physiologic/pathophysiologic significance of an adipocyte renin-angiotensin system Thacher S et al. Mol Cell Endocrinol. 2009; 29:

36 Obesity associated adipocyte dysfunction contributes to hypertension by endocrine and paracrine effects of adipokines on endothelial cells, VSMCs and macrophages Zhou J. and Qin G., Am. J. Cardiovacular Dis., 2012, 2,

37 Ehrhart-Bornstein M et al.: Proc Natl Acad Sci U S A. 2003; 100:

38 Relationship between visceral obesity and both sald dependend hypertesion and chronic kidney disease Fujita T. Nephrol. Dial. Transplant., 2007; 22:

39 Adiponectin inhibits permeability across a podocyte monolayer Ahima R. J. Clin. Invest. 2008, 118:

40 Role of leptin and adiponectin in glomerulopathies Mathew et al., Cur. Diab. Rev., 2011,7, 41-49,

41 Bone metabolism regulated by adipocytes, osteoblast and osteocalcin Cao J.J., J. Orthopedic Surg. Res., 2011, 6,30

42 Potential mechanisms by which resisitin may mediate cardiovascular dysfunction Jamaluddin M.S. et al., Brit. J. Pharmacol., 2012, 165,

43 Estimated glomerular filtration rate (egfr) according to quartiles of serum resistin concentrations and the age- and sex-adjusted mean values of serum resistin levels according to egfr Kawamura R et al. Nephrol. Dial. Transplant. 2010;25: The Author Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org

44 Hospitalization free survival according to the quartiles of serum resistin levels in hemodialysis patients Chung W. et al. J. Korean Med. Sci., 2012, 27,

45 Serum chemerin concentration and egfr in healthy controls, patients with ESRD before and 3 months after kidney transplantation Rutkowski P. et al. Regulatory Peptides, 2012, 173, 55-59

46 Survival curves for all-cause mortality among 252 incident dialysis patients according to the chemerin levels Yamamoto T. et al., Nephrol. Dial. Transplant., 2010, 25,

47 Association between plasma ometin levels and metabolic risks factors Shibata R. et al., Diabetology, Metab. Syndrom, 2012, 4, 2-4

48 Serum omentin 1 levels in normal glucose tolerance group, type 2 diabetes patients without carotid plaque and type 2 diabetes with carotid plaque Yoo H.J. et al. Cardiovacular Diab., 2011,10, 103

49 Serum omentin levels in haemodialysis patients Alcelik A. et al., Kidney Blood Pres. Res., 2012, 35,

50 Conclusions: Adipokines, a 2012 up-date New adipokines have been discovered (e.g. chemerin, ometin) Role of adipokines in pathogenesis of CKD progression, CV co-morbidities and uraemic toxicity was confirmed Still not enough information concerning the therapeutic utilization of this novel information

51 Thank you for very much your attention! Andrzej Wiecek Katowice

52 Plasma visfatin levels and appetite in CKD 5 patients starting dialysis therapy Carrero J.J. et al., Nephrol. Dial. Transplant, 2010, 25,

53 Adipokines as uremic toxins Teta D., J. Renal Nutrition, 2012, 22, 81-85

Obesity and the kidney

Obesity and the kidney 22. NATIONAL CONGRESS OF RENAL DISEASES, DIALYSIS & TRANSOPLANATATION NURSING 29. NATIONAL CONGRESS OF NEPHROLOGY, HYPEERTENSION DIALYSIS & TRANSPLANTATION 14-18 November 2012 Obesity and the kidney Prof.

More information

Role of the fat tissue in the pathogenesis of arterial hypertension and chronic kidney disease

Role of the fat tissue in the pathogenesis of arterial hypertension and chronic kidney disease The 17th Budapest Nephrology School (Nephrology, Hypertension, Dialysis, Transplantation) Under the auspices of ISN, ERA-EDTA and ISP 26-31 August, 2010 Role of the fat tissue in the pathogenesis of arterial

More information

Metabolic Syndrome, Obesity, Hypertension and Chronic Kidney Disease

Metabolic Syndrome, Obesity, Hypertension and Chronic Kidney Disease The 19th Budapest Nephrology School xyz (Nephrology, Hypertension, Dialysis, Transplantation) 26-31 August 2012 Metabolic Syndrome, Obesity, Hypertension and Chronic Kidney Disease Prof. Andrzej Więcek,

More information

Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University

Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,

More information

3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.

3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H. U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,

More information

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY JOSHUA K. KAYIMA ASSOCIATE PROFESSOR DEPT. OF CLINICAL MEDICINE AND THERAPEUTICS UNIVERSITY OF NAIROBI Introduction According to

More information

An update on the obesity epidemics in CKD and in ESRD. Does it really matter?

An update on the obesity epidemics in CKD and in ESRD. Does it really matter? EURECA-m 2011 An update on cutting-edge Cardiovascular and Renal Medicine themes. An update on the obesity epidemics in CKD and in ESRD. Does it really matter? Francesca Mallamaci BMI>30 25 Ireland 20

More information

Obesity mediated hypertension and renal dysfunction

Obesity mediated hypertension and renal dysfunction Obesity mediated hypertension and renal dysfunction Gergely Bodor Marion Hervouet Nicky Honnef Mariarosaria Malgadi Julie Robert Tutor: Pr Alina Parvu Objectives 1. Introduction 2. Renal structural and

More information

Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen

Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen Cardiovascular Complications Of Chronic Kidney Disease Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen Markers of kidney dysfunction Raised Albumin / Creatinine

More information

Prof. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland.

Prof. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland. What could be the role of renal denervation in chronic kidney disease? Andrzej Wiecek, Katowice, Poland Chairs: Peter J. Blankestijn, Utrecht, The Netherlands Jonathan Moss, Glasgow, UK Prof. Andrzej Wiecek

More information

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health

More information

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients Cardiovascular Mortality: General Population vs ESRD Dialysis Patients Annual CVD Mortality (%) 100 10 1 0.1 0.01 0.001 25-34 35-44 45-54 55-64 66-74 75-84 >85 Age (years) GP Male GP Female GP Black GP

More information

Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine

Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Setting the scene GB, 43 yo AA man followed for hypothyroidism returns on LT4 125 mcg/d and has a TSH=1.1

More information

Obesity, Metabolic Syndrome, and Diabetes: Making the Connections

Obesity, Metabolic Syndrome, and Diabetes: Making the Connections Obesity, Metabolic Syndrome, and Diabetes: Making the Connections Alka M. Kanaya, M.D. Associate Professor of Medicine & Epi/Biostats University of California, San Francisco February 26, 21 Roadmap 1.

More information

Obesity in the pathogenesis of chronic disease

Obesity in the pathogenesis of chronic disease Portoroz October 16th 2013 Obesity in the pathogenesis of chronic disease Rocco Barazzoni University of Trieste Department of Medical, Surgical and Health Sciences Obesity Trends* Among U.S. Adults BRFSS,

More information

ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ

ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΘΩΜΑΣ ΠΑΠΑΔΟΠΟΥΛΟΣ, MD, PHD ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΙΑΤΡΙΚΟ ΔΙΑΒΑΛΚΑΝΙΚΟ ΚΕΝΤΡΟ Inflammation as a cause of disease has entered the popular imagination. Diet ( macronutrients )

More information

Dietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components?

Dietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components? Dietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components? 3 rd International Conference of European Renal Nutrition Working Group of ERA-EDTA

More information

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien

More information

Metabolic Syndrome: Bad for the Heart and Bad for the Brain? Kristine Yaffe, MD Univ. of California, San Francisco

Metabolic Syndrome: Bad for the Heart and Bad for the Brain? Kristine Yaffe, MD Univ. of California, San Francisco Metabolic Syndrome: Bad for the Heart and Bad for the Brain? Kristine Yaffe, MD Univ. of California, San Francisco Why would diabetes and obesity be bad for the brain? Insulin receptors in brain Insulin

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information

Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes

Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu

More information

Roadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total

Roadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total Diabetes and the Metabolic Syndrome in the Asian Population Alka Kanaya, MD Associate Professor of Medicine, UCSF Feb 26, 2010 Roadmap 1. Diabetes in Asian Americans Prevalence in the U.S. Risk factors

More information

For Asian individuals the BMI numbers are 27.5 and 25 respectively These values are from the NICE guidelines of 2014

For Asian individuals the BMI numbers are 27.5 and 25 respectively These values are from the NICE guidelines of 2014 Ken Cathcart DO FACE We need to define several things to start the talk Obesity is defined medically as a BMI of greater than 30 or a BMI >27 with co-morbidities such as hypertension, type 2 DM, dyslipidemia,

More information

HSN301 Diet and Disease Entire Note Summary

HSN301 Diet and Disease Entire Note Summary Topic 1: Metabolic Syndrome Learning Objectives: 1. Define obesity 2. Factors causing obesity 3. Obesity as a risk factor for metabolic syndrome 4. The pathogenesis of metabolic syndrome 5. Treatment of

More information

HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME

HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME What does the term Metabolic Syndrome describe? Metabolic syndrome describes a cluster of cardio-metabolic conditions that increase one's risk of developing

More information

Morbidity & Mortality from Chronic Kidney Disease

Morbidity & Mortality from Chronic Kidney Disease Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report

More information

In The Name Of God. In The Name Of. EMRI Modeling Group

In The Name Of God. In The Name Of. EMRI Modeling Group In The Name Of God In The Name Of God EMRI Modeling Group Cells work together in functionally related groups called tissues Types of tissues: Epithelial lining and covering Connective support Muscle movement

More information

Fructose, Uric Acid and Hypertension in Children and Adolescents

Fructose, Uric Acid and Hypertension in Children and Adolescents Fructose, Uric Acid and Hypertension in Children and Adolescents Daniel I. Feig, MD, PhD, MS Director, Division of Nephrology Department of Pediatrics University of Alabama, Birmingham Topics for Discussion

More information

Psoriasis and the metabolic syndrome

Psoriasis and the metabolic syndrome Psoriasis and the metabolic syndrome MD, PhD James G. Krueger 1 Inflammation as a foundation of metabolic dysregulation and cardiovascular disease risk Diseases of systemic immune activation and inflammation,

More information

Metabolic Syndrome in Asians

Metabolic Syndrome in Asians Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly

More information

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as

More information

BIOL212 Biochemistry of Disease. Metabolic Disorders - Obesity

BIOL212 Biochemistry of Disease. Metabolic Disorders - Obesity BIOL212 Biochemistry of Disease Metabolic Disorders - Obesity Obesity Approx. 23% of adults are obese in the U.K. The number of obese children has tripled in 20 years. 10% of six year olds are obese, rising

More information

Empower Preventive Medicine. Timothy J. McCormick, DO, MPH 4221 Baymeadows Suite 6 Jacksonville, FL

Empower Preventive Medicine. Timothy J. McCormick, DO, MPH 4221 Baymeadows Suite 6 Jacksonville, FL Empower Preventive Medicine Timothy J. McCormick, DO, MPH 4221 Baymeadows Suite 6 Jacksonville, FL 32217 904-367-4005 Drtim@emprevmed.com Obesity Medicine Old paradigm: Obesity was a matter of willpower,

More information

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD

More information

Stefanos K. Roumeliotis. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece. Stefanos K.

Stefanos K. Roumeliotis. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece. Stefanos K. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece Passive, degenerative accumulation process of Ca ++ /P +++ without treatment options Active, complex, condition:

More information

FOCUS ON CARDIOVASCULAR DISEASE

FOCUS ON CARDIOVASCULAR DISEASE The Consequences of Vitamin D Deficiency: FOCUS ON CARDIOVASCULAR DISEASE Vitamin D deficiency is a global health problem. With all the medical advances of the century, vitamin D deficiency is still epidemic.

More information

Arteriosclerosis & Atherosclerosis

Arteriosclerosis & Atherosclerosis Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,

More information

METABOLISM of ADIPOSE TISSUE

METABOLISM of ADIPOSE TISSUE METABOLISM of ADIPOSE TISSUE 2. LF UK Prof. Rudolf Poledne, PhD. TYPES OF ADIPOSE TISSUE brown adipose tissue subcutaneous adipose tissue visceral adipose tissue ADIPOSE TISSUE FUNCTIONS: thermal isolation

More information

Estrogens vs Testosterone for cardiovascular health and longevity

Estrogens vs Testosterone for cardiovascular health and longevity Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

02/27/2018. Objectives. To Replace or Not to Replace: Nutritional Vitamin D in Dialysis.

02/27/2018. Objectives. To Replace or Not to Replace: Nutritional Vitamin D in Dialysis. To Replace or Not to Replace: Nutritional Vitamin D in Dialysis. Michael Shoemaker-Moyle, M.D. Assistant Professor of Clinical Medicine Objectives Review Vitamin D Physiology Review Current Replacement

More information

Changes in Cardiotrophin-1 and Fibroblast Growth Factor-21 with Weight Loss. Robert Lawrence Bowers

Changes in Cardiotrophin-1 and Fibroblast Growth Factor-21 with Weight Loss. Robert Lawrence Bowers Changes in Cardiotrophin-1 and Fibroblast Growth Factor-21 with Weight Loss by Robert Lawrence Bowers A dissertation submitted to the Graduate Faculty of Auburn University in partial fulfillment of the

More information

A real life example In human studies, we quantify ~120 plasma related proteins Monocytes MMP9 Macrophages TNFα IL1ß platelet derived growth factor IFNγ MMP1 MMP8 MMP13 Myeloid Related Protein14 CD40

More information

Setting the standard

Setting the standard SCLEROSTIN in NEPHROLOGY MOST REFERENCED OPTIMIZED FOR CLINICAL SAMPLES Setting the standard for clinical research. SCLEROSTIN A BONE-RELATED PROTEIN URINE PROTOCOL AVAILABLE Sclerostin ELISA - Assay Characteristics

More information

2011, Editrice Kurtis

2011, Editrice Kurtis J. Endocrinol. Invest. : -, 2011 DOI: 10.2/902 The role of visfatin in the pathogenesis of gestational diabetes mellitus D.E. Gok 1, M. Yazici 1, G. Uckaya 1, S.E. Bolu 1, Y. Basaran 2, T. Ozgurtas, S.

More information

Diabetes and Concomitant Cardiovascular Disease: Guideline Recommendations and Future Directions

Diabetes and Concomitant Cardiovascular Disease: Guideline Recommendations and Future Directions Diabetes and Concomitant Cardiovascular Disease: Guideline Recommendations and Future Directions Diabetes is one of the largest global health emergencies of 21 st century, with the number of people with

More information

Non Conventional cardiovascular risk factors in CKD

Non Conventional cardiovascular risk factors in CKD Non Conventional cardiovascular risk factors in CKD Death rates for major cardiovascular diseases have decreased in the United States Cooper, R, Cutler, J, Desvigne-Nickens, P, et al. Circulation 2000;

More information

Cardiovascular Protection and the RAS

Cardiovascular Protection and the RAS Cardiovascular Protection and the RAS Katalin Kauser, MD, PhD, DSc Senior Associate Director, Boehringer Ingelheim Pharmaceutical Inc. Micardis Product Pipeline Scientific Support Ridgefield, CT, USA Cardiovascular

More information

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,

More information

Research Article Serum and Vitreous Concentrations of Omentin-1 in Diabetic Retinopathy

Research Article Serum and Vitreous Concentrations of Omentin-1 in Diabetic Retinopathy Disease Markers Volume 2015, Article ID 754312, 4 pages http://dx.doi.org/10.1155/2015/754312 Research Article Serum and Vitreous Concentrations of Omentin-1 in Diabetic Retinopathy Wencui Wan, Qiuming

More information

Pongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD. Mahidol University

Pongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD. Mahidol University Roles oesof Fetuin-A in Hypertension Pongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD Ramathibodi Hospital Mahidol University Fetuin-A (Alpha-2-HS-glycoprotein) Multi-functional protein secreted by

More information

902 Biomed Environ Sci, 2014; 27(11):

902 Biomed Environ Sci, 2014; 27(11): 902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type

More information

Fructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희

Fructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희 Fructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희 Introduction Unique characteristics of Fructose Metabolism Mechanism for Fructose-Induced Insulin Resistance Epidemiological Studies

More information

Pathophysiology of Lipid Disorders

Pathophysiology of Lipid Disorders Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history

More information

New therapeutic targets for T2DM

New therapeutic targets for T2DM New therapeutic targets for T2DM Targeting inflammation: NF- B, salsalate Gwanpyo Koh Department of Internal Medicine Jeju National University School of Medicine Introduction Obesity is occurring at epidemic

More information

Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease

Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease Xin-Liang Ma, MD, PhD Thomas Jefferson University Philadelphia, PA USA CVD As The #1 Causes of Death In USA Male Female Heart Disease and

More information

Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies

Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Copyright 2016. All Rights Reserved. Property of Theratechnologies Inc. Mechanism of Action of Tesamorelin

More information

Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure

Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure CI Liakos, 1 EA Sanidas, 1 DN Perrea, 1 V Gennimata, 1 V Chantziara, 1 CA Grassos, 2 N-A Viniou, 1 JD Barbetseas,

More information

Targeting Adipose Tissue in Rheumatoid Arthritis TARA study HOFFA L SCAPTIPL 0.1013606 0.270906 0.3759505 0.3373511 0.4050987 0.404667 11.6 DISCUSSIONS The study targeted the serum levels of adipokines

More information

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of

More information

Diabetes in Asian Americans

Diabetes in Asian Americans Diabetes in Asian Americans www.screenat23.org Winston F. Wong, MD National Council of Asian Pacific Islander Physicians www.ncapip.org American Diabetes Association Joslin Diabetes Center National Council

More information

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:

More information

IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS

IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS Kedikova S. MD, PhD Medical University Sofia, Bulgaria University Hospital Maichin dom Sofia NUTRITION WHO - Nutrition is the intake of

More information

* Author to whom correspondence should be addressed; Tel.: ; Fax:

* Author to whom correspondence should be addressed;   Tel.: ; Fax: Int. J. Mol. Sci. 2014, 15, 6184-6223; doi:10.3390/ijms15046184 Review OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Obesity and Its Metabolic Complications:

More information

Effects of Exercise and Physical Activity on Diabetes Mellitus and Obesity

Effects of Exercise and Physical Activity on Diabetes Mellitus and Obesity 1 EXERCISE IS MEDICINE: The Science Behind the Movement Effects of Exercise and Physical Activity on Diabetes Mellitus and Obesity Rosa Allyn G. Sy, MD, FPCP, FPSEDM Endocrinology, Diabetes, Metabolism

More information

Cardiovascular Pharmacotherapy in Special Population: Cardio-Nephrology

Cardiovascular Pharmacotherapy in Special Population: Cardio-Nephrology 49 th Annual Scientific Meeting The Heart Association of Thailand under the Royal Patronage of H.M. the King Cardiology on the move 24-25 March 2017 @Sheraton, HuaHin Cardiovascular Pharmacotherapy in

More information

Tomasz J Guzik. Diabetes, perivascular adipose tissue and inflammation.

Tomasz J Guzik. Diabetes, perivascular adipose tissue and inflammation. Tomasz J Guzik Diabetes, perivascular adipose tissue and inflammation. Translational Research Laboratory Department of Internal and Agricutural Medicine Jagiellonian University School of Medicine Cracow,

More information

Nutritional Cases with CKD HEMODIALYSIS

Nutritional Cases with CKD HEMODIALYSIS Nutritional Cases with CKD HEMODIALYSIS S. Muge DEGER, MD, FISN Yuksek Ihtisas University Faculty of Medicine, Koru Hospital Department of Nephrology Ankara, TURKEY CASE-1 BC, is a 60- year- old Caucasian

More information

Malnutrition in advanced CKD

Malnutrition in advanced CKD Malnutrition in advanced CKD Malnutrition Lack of proper nutrition, caused by not having enough to eat, not eating enough of the right things or being unable to use the food that one does eat Jessica Stevenson

More information

Sleep Apnoea : its impact outside the chest. Dr Tom Mackay Consultant Respiratory Physician Royal Infirmary Edinburgh

Sleep Apnoea : its impact outside the chest. Dr Tom Mackay Consultant Respiratory Physician Royal Infirmary Edinburgh Sleep Apnoea : its impact outside the chest Dr Tom Mackay Consultant Respiratory Physician Royal Infirmary Edinburgh Body Mass Index < 20 kg/m 2 20-25 kg/m 2 25-30 kg/m 2 > 30 kg/m 2 underweight normal

More information

Child born in year /3 will die before parents in US (diabetes)

Child born in year /3 will die before parents in US (diabetes) Child born in year 2000-1/3 will die before parents in US (diabetes) ATP III identified 6 components of the metabolic syndrome that relate to CVD 1. Abdominal obesity 2. Atherogenic dyslipidemia (elevated

More information

DOWNLOAD PDF ADIPOSE TISSUE AND ADIPOKINES IN HEALTH AND DISEASE (NUTRITION AND HEALTH)

DOWNLOAD PDF ADIPOSE TISSUE AND ADIPOKINES IN HEALTH AND DISEASE (NUTRITION AND HEALTH) Chapter 1 : Adiposity, Adipokines, and Adiposopathy - Sick Fat Explained Adipose Tissue and Adipokines in Health and Disease, Second Edition is a useful resource for physicians interested in adipose tissue

More information

Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance.

Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance. ORIGINAL ARTICLE Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance. Bonneau GA y Pedrozo WR 1 Ministry of Public Health, Province of Misiones, 2 School of Exact, Chemical

More information

Digestion: Endocrinology of Appetite

Digestion: Endocrinology of Appetite Digestion: Endocrinology of Dr. Ritamarie Loscalzo Medical Disclaimer: The information in this presentation is not intended to replace a one on one relationship with a qualified health care professional

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

CAN WE PREDICT THE RISK FOR ADVERSE EVENTS? Andrzej Wiecek, Katowice, Poland

CAN WE PREDICT THE RISK FOR ADVERSE EVENTS? Andrzej Wiecek, Katowice, Poland CAN WE PREDICT THE RISK FOR ADVERSE EVENTS? Andrzej Wiecek, Katowice, Poland Chair: Kai- Uwe Eckardt, Erlangen, Germany Pierre- Yves Martin, Geneva, Switzerland Prof. Andrzej Więcek Departm ent of Nephrology,

More information

Long-term study of the association of adipokines and glucose variability with diabetic complications

Long-term study of the association of adipokines and glucose variability with diabetic complications ORIGINAL ARTICLE Korean J Intern Med 2018;33:367-382 Long-term study of the association of adipokines and glucose variability with diabetic complications Jin Joo Cha, Hye Sook Min, Kitae Kim, Mi Jin Lee,

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

JMSCR Vol 07 Issue 01 Page January 2019

JMSCR Vol 07 Issue 01 Page January 2019 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i1.66 Lipid Profile in Different Stages

More information

Krediet slide di 18

Krediet slide di 18 1 di 18 Assessment of fluid status in PD patients Raymond T. Krediet, Amsterdam, Netherlands Chairs:Walther H. Boer, Utrecht, The Netherlands F. Fevzi Ersoy, Antalya, Turkey Prof. Raymond T. Krediet DDivision

More information

Cardiovascular Risk Reduction in Kidney Transplant Recipients

Cardiovascular Risk Reduction in Kidney Transplant Recipients Cardiovascular Risk Reduction in Kidney Transplant Recipients Rainer Oberbauer R.O. AUG 2010 CV Mortality in ESRD compared to the general population R.O.2/32 Modified from Foley et al. AJKD 32 (suppl3):

More information

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage

More information

Getting Ahead of the Curve in the Trouble with Fat

Getting Ahead of the Curve in the Trouble with Fat Getting Ahead of the Curve in the Trouble with Fat Zhaoping Li, M.D., Ph.D. Professor of Medicine David Geffen School of Medicine, UCLA VA Greater Los Angeles Health Care System Obesity Pandemic Predicted

More information

Hemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK

Hemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK Hemodiafiltration: principles and advantages over conventional HD Rukshana Shroff Great Ormond Street Hospital for Children London, UK Effectiveness of RRT modalities Mcfarlane, Seminars in dialysis, 2009

More information

Effects of growth hormone secretagogue receptor agonist and antagonist in nonobese type 2 diabetic MKR mice

Effects of growth hormone secretagogue receptor agonist and antagonist in nonobese type 2 diabetic MKR mice Effects of growth hormone secretagogue receptor agonist and antagonist in nonobese type 2 diabetic MKR mice Rasha Mosa (MBCHC, M.D, PhD candidate) School of Biomedical Sciences University of Queensland

More information

Obesity and Chronic Kidney. The Catholic University of Korea Cheol Whee Park, M.D.

Obesity and Chronic Kidney. The Catholic University of Korea Cheol Whee Park, M.D. Obesity and Chronic Kidney Disease The Catholic University of Korea Cheol Whee Park, M.D. Epidemic Obesity and type 2 Diabetes in Asia Yoon KH, et al. Lancet 368:1681-1688, 2006 [1 단계 ] 지방세포가커진다 [2 단계

More information

( ) , (Donabedian, 1980) We would not choose any treatment with poor outcomes

( ) , (Donabedian, 1980) We would not choose any treatment with poor outcomes ..., 2013 Amgen. 1 ? ( ), (Donabedian, 1980) We would not choose any treatment with poor outcomes 1. :, 2. ( ): 3. :.,,, 4. :, [Biomarkers Definitions Working Group, 2001]., (William M. Bennet, Nefrol

More information

What is New in the Pathogenesis of Salt-sensitive Hypertension?

What is New in the Pathogenesis of Salt-sensitive Hypertension? What is New in the Pathogenesis of Salt-sensitive Hypertension? Prof. Andrzej Wiecek Department of Nephrology, Transplantation and Internal Medicine Medical University of Silesia, Katowice, Poland e-mail:

More information

Metabolic Syndrome. DOPE amines COGS 163

Metabolic Syndrome. DOPE amines COGS 163 Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance

More information

Attivazione selettiva dei VDR nella CKD-MBD: dalla conservativa alla dialisi

Attivazione selettiva dei VDR nella CKD-MBD: dalla conservativa alla dialisi Attivazione selettiva dei VDR nella CKD-MBD: dalla conservativa alla dialisi Mario Cozzolino, MD, PhD, FERA Dipartimento di Scienze della Salute Università di Milano UO Nefrologia e Dialisi Laboratorio

More information

ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world

ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world Nutrition in Kidney Disease: How to Apply Guidelines to Clinical Practice? T. Alp

More information

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria 1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage

More information

Targeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study

Targeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study Targeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford

More information

The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease

The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease Steve Smith, Group Director Scientific Affairs, Diabetes & Metabolism GlaxoSmithKline R & D

More information

The true cost of inpatient obesity impact on inflammatory stress and morbidity.

The true cost of inpatient obesity impact on inflammatory stress and morbidity. The true cost of inpatient obesity impact on inflammatory stress and morbidity. Professor Bob Grimble, Institute of Human Nutrition, Institute of Developmental Sciences Building, University of Southampton

More information

Establishment of Efficacy of Intervention in those with Metabolic Syndrome. Dr Wendy Russell - ILSI Europe Expert Group

Establishment of Efficacy of Intervention in those with Metabolic Syndrome. Dr Wendy Russell - ILSI Europe Expert Group Establishment of Efficacy of Intervention in those with Metabolic Syndrome Dr Wendy Russell - ILSI Europe Expert Group Conflict of interest regarding this presentation: I have no conflict of interest to

More information

Clinical Role of Inflammation in Metabolic Diseases

Clinical Role of Inflammation in Metabolic Diseases Clinical Role of Inflammation in Metabolic Diseases Won-Young Lee Department of Endocrinology and Metabolism Kangbuk Samsung Hospital Sungkyunkwan University Medical School, Seoul, Korea (2009-Nov-19)

More information

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes

More information

Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome

Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University

More information

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia

More information